RESEARCH CATALOG
CJC-1295 + Ipamorelin
CJC-1295 with ipamorelin is listed in the Peptide Tactics catalog and available to order for research use in India, supplied as a single vial containing 5 mg of each. Searches for CJC 1295 Ipamorelin or CJC1295 Ipamorelin refer to this listing. Because the vial contains two chemically distinct peptides, a single purity figure cannot describe it, and the analytical section below explains what per-component reporting means for documentation.
This catalog entry contains two chemically distinct peptides supplied in a single vial: CJC-1295 and ipamorelin, at 5 mg each. Because it is a two-component material, characterising it is a different exercise from characterising a single peptide.
Enquiries are completed over WhatsApp or email. Peptide Tactics provides information and distribution for qualified research use. See the research-use policy before ordering.
Also written as
CJC 1295 Ipamorelin · CJC1295 Ipamorelin · CJC-1295 and ipamorelin blend
Compound identity
| Components | CJC-1295 and ipamorelin(catalog information) |
|---|---|
| Stated quantity | 5 mg / 5 mg(catalog information) |
| CJC-1295 molecular weight (DAC form) | 3647.2 g/mol(PubChem CID 91971820) |
| Ipamorelin molecular weight | 711.9 g/mol(PubChem CID 9831659) |
| Catalog format | 5 mg / 5 mg • lyophilized powder(catalog information) |
Each row above is attributed to its source. Rows citing a database record are reference information about the molecule; rows marked catalog information describe this listing. Neither is a specification, an analytical result or a claim about any particular batch.
Research classification
Two-component research material containing a synthetic GHRH analog and a synthetic pentapeptide. Not an approved medicine.
Chemical characteristics
- The two components differ in mass by roughly a factor of five, so both should resolve clearly in mass spectrometry and are unlikely to be confused with one another.
- A chromatographic purity figure for a two-component vial needs careful reading: a single percentage figure cannot describe two intended components at once, so per-component reporting is more informative.
- The relative ratio of the two components is a meaningful quality attribute for a blend, in a way that it is not for a single-peptide vial.
Analytical methods
- Reversed-phase HPLC (RP-HPLC) is the method most commonly used to express the chromatographic purity of a synthetic peptide as a percentage of total peak area at a stated wavelength.
- Mass spectrometry (typically ESI-MS or MALDI-TOF) is used to confirm that the observed mass of the material is consistent with the expected mass of the intended sequence.
- Because purity figures are method-dependent, an analytical result is only interpretable alongside the method conditions and the batch it describes.
Both methods are covered in more detail in our guides to HPLC analysis of peptides and mass spectrometry for identity confirmation.
Stability and storage considerations
- Lyophilized peptides are generally supplied as a dry solid because the removal of water slows hydrolytic degradation pathways.
- Cold, dry, light-protected storage is the general handling expectation for lyophilized research peptides.
- Once a peptide is taken into solution, its stability profile changes and is influenced by solvent, pH, temperature and the number of freeze-thaw cycles.
- Storage and handling expectations for a specific batch should be taken from that batch's documentation rather than from general guidance.
See peptide stability and degradation for the chemistry behind these considerations.
What this page does not claim
- Documentation for a blend should state which CJC-1295 form is present, DAC or non-DAC, because the two are different molecules.
- Peptide Tactics does not publish batch analytical data on this page. Documentation availability should be confirmed before ordering.
Independent Analytical Documentation
Janoshik Analytical verification
Catalog products are independently verified through Janoshik Analytical. Certificates of analysis from that laboratory are issued per product and per batch — not as a single generic document for the whole catalog — so the report you receive describes the material you are ordering.
Should you require a Janoshik COA for CJC-1295 + Ipamorelin, write to us on WhatsApp and we will provide the applicable report for that product.
We do not currently publish a full independent analytical report on this page for the CJC-1295 + Ipamorelin listed here. That does not mean documentation is unavailable — it means the report is supplied on request for the batch being fulfilled, rather than attached permanently to a catalog listing that outlives any one batch.
If a report is a requirement for your work, ask before ordering. We will check what Janoshik or other documentation covers the current batch and tell you what it is. Where nothing exists for that batch, we will say so.
Reading the documentation matters as much as having it. Our guides on how to read a peptide certificate of analysis and what a purity figure does and does not mean cover what to look for, and our documentation page explains the request process.
Ordering CJC-1295 + Ipamorelin in India
CJC-1295 + Ipamorelin is ordered through the catalog and finalised over WhatsApp or email, so that any question about specification or documentation is settled before the order is placed rather than after it.
Immediate dispatch whenever couriers are operating. Orders from Bangalore are dispatched immediately whenever courier operations are open. Orders from elsewhere in India are dispatched as soon as couriers are operating.
Distribution is within India. Material is supplied for in-vitro research and analytical applications only, and we do not supply for human or veterinary use.
Frequently asked questions
- Can I buy CJC-1295 with ipamorelin in India from Peptide Tactics?
- Yes. The blend is listed as a single vial containing 5 mg of CJC-1295 and 5 mg of ipamorelin, with the price shown on this page, available to order for research use within India.
- What documentation can I request for this blend?
- You can request whatever documentation exists for the batch supplied. For a two-component vial the useful question is whether the documentation reports each peptide separately, because one combined purity figure cannot describe a vial with two intended components. We will tell you what the batch documentation covers before you order, and we do not hold a published independent analytical report for the material currently listed.
- How quickly are orders dispatched?
- Dispatch is immediate whenever courier services are operating. Bangalore orders take priority in the dispatch queue; orders from elsewhere in India go out as soon as couriers are running, and anything received outside courier hours is dispatched when they reopen. We do not quote a delivery date, because transit time is the courier's and not ours.
- Can you source a peptide that is not listed?
- Yes. Our catalog is what we currently hold, not the limit of what we can look into. Send the compound name, quantity and any specification that matters — salt form, purity threshold, documentation requirement — and we will investigate sourcing options and tell you what is possible, what it would cost and what documentation exists.
- Is this blend intended for human use?
- No. Everything in this catalog is supplied for in-vitro research and analytical applications only, and not for human or veterinary use. We do not provide dosing, administration guidance or any therapeutic recommendation, and we cannot supply material for those purposes.
- What is in the CJC-1295 + ipamorelin catalog item?
- It is a single vial containing two distinct synthetic peptides, CJC-1295 and ipamorelin, at a stated 5 mg each.
- How is a two-peptide vial analysed differently from a single peptide?
- A blend needs per-component reporting. A single overall purity percentage cannot meaningfully describe a vial with two intended components, and the ratio between the components becomes a quality attribute in its own right.
- Which form of CJC-1295 is used?
- That should be stated in the documentation for the specific batch, because the DAC and non-DAC forms are different molecules. Contact us if you need this confirmed before ordering.
Sources
Can't Find the Compound You Need?
Our catalog lists what we currently hold, and it is not the full range of research materials we can look into. If you need a compound that is not listed, tell us what you are looking for and we will investigate sourcing options for it.
Useful things to include in your enquiry:
- The compound name, and any code or CAS number you have for it.
- Quantity per vial, and how many vials.
- Any specification that matters to your work — salt form, purity threshold, or the analytical method you need it reported against.
- Whether batch documentation or an independent analytical report is a requirement, so we can establish up front whether it is available.
We will tell you what we can source, what it would cost and what documentation exists. Where we cannot source something, or cannot establish its documentation, we will say so rather than take the order.
Sourcing enquiries are accepted for in-vitro research and analytical use only. We cannot supply material for human or veterinary use, and we do not advise on how any compound should be used.
Related compounds
CJC-1295
CJC-1295 reference information for researchers in India: what the name covers, how the DAC and non-DAC forms differ, and the molecular data on record.
View compound pageIpamorelin
Ipamorelin reference information for researchers in India: pentapeptide composition, molecular formula, molecular weight and classification.
View compound pageFurther reading
- Understanding peptide certificates of analysis — A certificate of analysis is a record of what was measured on a specific batch.
- Peptide purity explained — A purity percentage on its own carries less information than it appears to.
- Mass spectrometry and peptide characterisation — Chromatography tells you how many species are present.